Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 1.97% is 63% below its 5-year average of 5.28%, around the middle of its 5-year range (-24.21%–33.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 82.77% below its 12-month average of 11.45%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 1.97%.
RETURN ON INVESTED CAPITAL (ROIC)
1.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
11.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
15.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
5.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
0.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-2.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-6.77%
CURRENT VS TTM AVG
-82.77%
CURRENT VS 3Y AVG
-87.51%
CURRENT VS 5Y AVG
-62.67%
CURRENT VS 10Y AVG
+14984.96%
CURRENT VS 15Y AVG
+167.08%
CURRENT VS 20Y AVG
+129.16%
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+105.53%
vs the sector median at left
MiMedx Group, Inc.
Market Cap
$668.50M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
11.45%
3Y Avg
15.79%
5Y Avg
5.28%
Market Cap
$669.30M
Return on Invested Capital (ROIC)
-101.43%
TTM Avg
-70.16%
3Y Avg
-61.78%
5Y Avg
-52.46%
Market Cap
$659.50M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$666.64M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
Market Cap
$673.84M
Return on Invested Capital (ROIC)
-44.30%
TTM Avg
-32.94%
3Y Avg
-36.44%
5Y Avg
-31.30%
Market Cap
$654.39M
Return on Invested Capital (ROIC)
-31.32%
TTM Avg
-38.51%
3Y Avg
-38.51%
5Y Avg
-38.51%
Market Cap
$684.87M
Return on Invested Capital (ROIC)
-54.12%
TTM Avg
-85.96%
3Y Avg
-71.51%
5Y Avg
-63.27%
Market Cap
$687.17M
Return on Invested Capital (ROIC)
-118.97%
TTM Avg
-130.14%
3Y Avg
-108.49%
5Y Avg
-89.69%
Market Cap
$693.61M
Return on Invested Capital (ROIC)
-42.94%
TTM Avg
-42.70%
3Y Avg
-94.89%
5Y Avg
-93.87%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiMedx Group, Inc. (MDXG) | $668.50M | 1.97% | 11.45% | 15.79% | 5.28% |
| Annexon, Inc. (ANNX)vs › | $669.30M | -101.43% | -70.16% | -61.78% | -52.46% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $659.50M | -47.96% | -47.20% | -41.20% | -37.18% |
| Helus Pharma Inc. (HELP)vs › | $666.64M | -73.27% | -60.64% | -63.77% | -62.42% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $673.84M | -44.30% | -32.94% | -36.44% | -31.30% |
| Starling Oncology, Inc. (STLN)vs › | $654.39M | -31.32% | -38.51% | -38.51% | -38.51% |
| Solid Biosciences Inc. (SLDB)vs › | $684.87M | -54.12% | -85.96% | -71.51% | -63.27% |
| Verastem, Inc. (VSTM)vs › | $687.17M | -118.97% | -130.14% | -108.49% | -89.69% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -42.94% | -42.70% | -94.89% | -93.87% |
| OmniAb, Inc. (OABI)vs › | $642.95M | -17.48% | -24.56% | -18.89% | -16.21% |
ROIC
2.0%
ROE
2.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 1.97% |
| 2026-03-31 | 10.81% |
| 2025-12-31 | 16.66% |
| 2025-09-30 | 15.03% |
| 2025-06-30 | 12.77% |
| 2025-03-31 | 17.27% |
| 2024-12-31 | 19.67% |
| 2024-09-30 | 31.19% |
| 2024-06-30 | 33.09% |
| 2024-03-31 | 28.07% |
| 2023-12-31 | 19.23% |
| 2023-09-30 | 15.04% |
| 2023-06-30 | 3.38% |
| 2023-03-31 | -12.58% |
| 2022-12-31 | -19.31% |
| 2022-09-30 | -17.91% |
| 2022-06-30 | -12.70% |
| 2022-03-31 | -5.43% |
| 2021-12-31 | -3.46% |
| 2021-09-30 | -17.60% |
| 2021-06-30 | -24.21% |
| 2021-03-31 | -28.44% |
| 2020-12-31 | -31.78% |
| 2020-09-30 | -21.91% |
| 2020-06-30 | -11.29% |
| 2020-03-31 | -21.72% |
| 2019-12-31 | -20.43% |
| 2019-09-30 | -23.01% |
| 2019-06-30 | -40.70% |
| 2019-03-31 | -47.12% |
| 2018-12-31 | -7.65% |
| 2017-12-31 | 61.27% |
| 2017-09-30 | 21.56% |
| 2017-06-30 | 14.54% |
| 2017-03-31 | 11.08% |
| 2016-12-31 | 8.56% |
| 2016-09-30 | 12.48% |
| 2016-06-30 | 14.07% |
| 2016-03-31 | 14.55% |
| 2015-12-31 | 22.32% |
| 2015-09-30 | 19.62% |
| 2015-06-30 | 18.10% |
| 2015-03-31 | 12.86% |
| 2014-12-31 | 6.89% |
| 2014-09-30 | 1.22% |
| 2014-06-30 | -3.88% |
| 2014-03-31 | -4.25% |
| 2013-12-31 | -3.51% |
| 2013-09-30 | -5.28% |
| 2013-06-30 | -6.48% |
| 2013-03-31 | -4.97% |
| 2012-12-31 | -6.61% |
| 2012-09-30 | -15.32% |
| 2012-06-30 | -22.74% |
| 2012-03-31 | -32.67% |
| 2011-12-31 | -47.67% |
| 2011-09-30 | -54.81% |
| 2011-06-30 | -58.41% |
| 2011-03-31 | -53.71% |
| 2010-12-31 | -161.94% |
| 2010-09-30 | -142.02% |
| 2010-06-30 | -93.07% |
| 2010-03-31 | -95.36% |
| 2009-09-30 | -178.59% |
| 2009-06-30 | -135.97% |
| 2009-03-31 | -202.43% |
| 2008-12-31 | -233521.17% |
| 2008-09-30 | -195727.89% |
| 2008-06-30 | -153652.65% |
| 2008-03-31 | -123345.83% |
